{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T22:02:37Z","timestamp":1791669757759,"version":"4.3.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,5,25]],"date-time":"2019-05-25T00:00:00Z","timestamp":1558742400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,25]],"date-time":"2019-05-25T00:00:00Z","timestamp":1558742400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s11255-019-02172-8","type":"journal-article","created":{"date-parts":[[2019,5,25]],"date-time":"2019-05-25T06:32:01Z","timestamp":1558765921000},"page":"1335-1342","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Therapeutic benefit of second-look transurethral resection of bladder tumors for newly diagnosed T1 bladder cancer: a single-center experience"],"prefix":"10.1007","volume":"51","author":[{"given":"Wen-Hsin","family":"Tseng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Liang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven K.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex Chien-Hwa","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinn-Rung","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun-Hsing","family":"Hun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Hao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Cheng","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jhih-Cheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kau-Han","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun-Hung","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,25]]},"reference":[{"key":"2172_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21387","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel RL, Miller KD, Jemal A (2017) Cancer statistics, 2017. CA Cancer J Clin 67:7\u201330","journal-title":"CA Cancer J Clin"},{"key":"2172_CR2","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.eururo.2012.07.033","volume":"63","author":"M Burger","year":"2013","unstructured":"Burger M, Catto JW, Dalbagni G et al (2013) Epidemiology and risk factors of urothelial bladder cancer. Eur Urol 63:234\u2013241","journal-title":"Eur Urol"},{"key":"2172_CR3","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1016\/j.juro.2014.01.087","volume":"191","author":"KA Richards","year":"2014","unstructured":"Richards KA, Smith ND, Steinberg GD (2014) The importance of transurethral resection of bladder tumor in the management of nonmuscle invasive bladder cancer: a systematic review of novel technologies. J Urol 191:1655\u20131664","journal-title":"J Urol"},{"key":"2172_CR4","unstructured":"National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (NCCN Guidelines). Bladder Cancer. 2019 Version 1. \n                    http:\/\/www.nccn.org\n                    \n                  . Accessed 20 Dec 2018"},{"key":"2172_CR5","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.eururo.2016.05.041","volume":"71","author":"M Babjuk","year":"2017","unstructured":"Babjuk M, B\u00f6hle A, Burger M et al (2017) EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur Urol 71:447\u2013461","journal-title":"Eur Urol"},{"key":"2172_CR6","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.eururo.2018.02.014","volume":"73","author":"MG Cumberbatch","year":"2018","unstructured":"Cumberbatch MG, Foerster B, Catto JW et al (2018) Repeat transurethral resection in non-muscle-invasive bladder cancer: a systematic review. Eur Urol 73:925\u2013933","journal-title":"Eur Urol"},{"key":"2172_CR7","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.euf.2016.12.011","volume":"4","author":"A Naselli","year":"2017","unstructured":"Naselli A, Hurle R, Paparella S et al (2017) Role of restaging transurethral resection for T1 non-muscle invasive bladder cancer: a systematic review and meta-analysis. Eur Urol Focus 4:558\u2013567","journal-title":"Eur Urol Focus"},{"key":"2172_CR8","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.urology.2014.06.005","volume":"84","author":"J Dobruch","year":"2014","unstructured":"Dobruch J, Bor\u00f3wka A, Herr HW (2014) Clinical value of transurethral second resection of bladder tumor: systematic review. Urology 84:881\u2013885","journal-title":"Urology"},{"key":"2172_CR9","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1089\/end.2011.0576","volume":"26","author":"W Kim","year":"2012","unstructured":"Kim W, Song C, Park S et al (2012) Value of immediate second resection of the tumor bed to improve the effectiveness of transurethral resection of bladder tumor. J Endourol 26:1059\u20131064","journal-title":"J Endourol"},{"key":"2172_CR10","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1007\/s11255-015-1048-3","volume":"47","author":"T Koie","year":"2015","unstructured":"Koie T, Ohyama C, Hosogoe S et al (2015) Oncological outcomes of a single but extensive transurethral resection followed by appropriate intra-vesical instillation therapy for newly diagnosed non-muscle-invasive bladder cancer. Int Urol Nephrol 47:1509\u20131514","journal-title":"Int Urol Nephrol"},{"key":"2172_CR11","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1089\/end.2008.0281","volume":"22","author":"KS Han","year":"2008","unstructured":"Han KS, Joung JY, Cho KS et al (2008) Results of repeated transurethral resection for a second opinion in patients referred for nonmuscle invasive bladder cancer: the referral cancer center experience and review of the literature. J Endourol 22:2699\u20132704","journal-title":"J Endourol"},{"key":"2172_CR12","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1111\/j.1464-410X.2006.06144.x","volume":"97","author":"HE Schwaibold","year":"2006","unstructured":"Schwaibold HE, Sivalingam S, May F et al (2006) The value of a second transurethral resection for T1 bladder cancer. BJU Int 97:1199\u20131201","journal-title":"BJU Int"},{"key":"2172_CR13","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/S0022-5347(05)00689-0","volume":"175","author":"T Divrik","year":"2006","unstructured":"Divrik T, Yildirim \u00dc, \u015ekin Ero\u011flu A et al (2006) Is a second transurethral resection necessary for newly diagnosed pT1 bladder cancer? J Urol 175:1258\u20131261","journal-title":"J Urol"},{"key":"2172_CR14","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.eururo.2010.03.007","volume":"58","author":"RT Divrik","year":"2010","unstructured":"Divrik RT, \u015eahin AF, Yildirim \u00dc et al (2010) Impact of routine second transurethral resection on the long-term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recurrence, progression rate, and disease-specific survival: a prospective randomised clinical trial. Eur Urol 58:185\u2013190","journal-title":"Eur Urol"},{"key":"2172_CR15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.4103\/0974-7796.163798","volume":"8","author":"K Hashine","year":"2016","unstructured":"Hashine K, Ide T, Nakashima T et al (2016) Results of second transurethral resection for high-grade T1 bladder cancer. Urol Ann 8:10\u201315","journal-title":"Urol Ann"},{"key":"2172_CR16","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.juro.2013.08.022","volume":"191","author":"JP Sfakianos","year":"2014","unstructured":"Sfakianos JP, Kim PH, Hakimi AA et al (2014) The effect of restaging transurethral resection on recurrence and progression rates in patients with nonmuscle invasive bladder cancer treated with intravesical bacillus Calmette\u2013Gu\u00e9rin. J Urol 191:341\u2013345","journal-title":"J Urol"},{"key":"2172_CR17","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.eururo.2011.03.051","volume":"60","author":"HW Herr","year":"2011","unstructured":"Herr HW, Dalbagni G, Donat SM (2011) Bacillus Calmette\u2013Gu\u00e9rin without maintenance therapy for high-risk non-muscle-invasive bladder cancer. Eur Urol 60:32\u201336","journal-title":"Eur Urol"},{"key":"2172_CR18","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.juro.2012.03.007","volume":"188","author":"HB Grossman","year":"2012","unstructured":"Grossman HB, Stenzl A, Fradet Y et al (2012) Long-term decrease in bladder cancer recurrence with hexaminolevulinate enabled fluorescence cystoscopy. J Urol 188:58\u201362","journal-title":"J Urol"},{"key":"2172_CR19","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.eururo.2016.03.053","volume":"70","author":"S Naito","year":"2016","unstructured":"Naito S, Algaba F, Babjuk M et al (2016) The Clinical Research Office of the Endourological Society (CROES) Multicentre Randomised Trial of Narrow Band Imaging-Assisted Transurethral Resection of Bladder Tumour (TURBT) versus conventional white light imaging-assisted TURBT in primary non-muscle-invasive bladder cancer patients: trial protocol and 1-year results. Eur Urol 70:506\u2013515","journal-title":"Eur Urol"},{"key":"2172_CR20","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s11255-018-1830-0","volume":"50","author":"J Zhang","year":"2018","unstructured":"Zhang J, Wang L, Mao S et al (2018) Transurethral en bloc resection with bipolar button electrode for non-muscleinvasive bladder cancer. Int Urol Nephrol 50:619\u2013623","journal-title":"Int Urol Nephrol"},{"key":"2172_CR21","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","volume":"49","author":"RJ Sylvester","year":"2006","unstructured":"Sylvester RJ, van der Meijden AP, Oosterlinck W et al (2006) Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 49:466\u2013477","journal-title":"Eur Urol"},{"key":"2172_CR22","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1016\/j.juro.2009.07.016","volume":"182","author":"J Fernandez-Gomez","year":"2009","unstructured":"Fernandez-Gomez J, Madero R, Solsona E et al (2009) Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette\u2013Guerin: the CUETO scoring model. J Urol 182:2195\u20132203","journal-title":"J Urol"},{"key":"2172_CR23","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11255-016-1441-6","volume":"49","author":"HM Li","year":"2017","unstructured":"Li HM, Azhati B, Rexiati M et al (2017) Impact of smoking status and cumulative smoking exposure on tumor recurrence of non-muscle-invasive bladder cancer. Int Urol Nephrol 49:69\u201376","journal-title":"Int Urol Nephrol"},{"key":"2172_CR24","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1007\/s11255-015-1013-1","volume":"47","author":"T Xu","year":"2015","unstructured":"Xu T, Zhu Z, Wang X et al (2015) Impact of body mass on recurrence and progression in Chinese patients with Ta, T1 urothelial bladder cancer. Int Urol Nephrol 47:1135\u20131141","journal-title":"Int Urol Nephrol"},{"key":"2172_CR25","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1007\/s11255-014-0719-9","volume":"46","author":"J Mashni","year":"2014","unstructured":"Mashni J, Godoy G, Haarer C et al (2014) Prospective evaluation of plasma kinetic bipolar resection of bladder cancer: comparison to monopolar resection and pathologic findings. Int Urol Nephrol 46:1699\u20131705","journal-title":"Int Urol Nephrol"},{"key":"2172_CR26","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1245\/s10434-016-5700-7","volume":"24","author":"JY Teoh","year":"2017","unstructured":"Teoh JY, Chan ES, Yip SY et al (2017) Comparison of detrusor muscle sampling rate in monopolar and bipolar transurethral resection of bladder tumor: a randomized trial. Ann Surg Oncol 24:1428\u20131434","journal-title":"Ann Surg Oncol"},{"key":"2172_CR27","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/j.1442-2042.2012.03174.x","volume":"20","author":"A Del Rosso","year":"2013","unstructured":"Del Rosso A, Pace G, Masciovecchio S et al (2013) Plasmakinetic bipolar versus monopolar transurethral resection of non-muscle invasive bladder cancer: a single center randomized controlled trial. Int J Urol 20:399\u2013403","journal-title":"Int J Urol"},{"key":"2172_CR28","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1016\/j.juro.2013.12.004","volume":"191","author":"V Venkatramani","year":"2014","unstructured":"Venkatramani V, Panda A, Manojkumar R et al (2014) Monopolar versus bipolar transurethral resection of bladder tumors: a single center, parallel arm, randomized, controlled trial. J Urol 191:1703\u20131707","journal-title":"J Urol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-019-02172-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-019-02172-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-019-02172-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T23:11:26Z","timestamp":1590275486000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-019-02172-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,25]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["2172"],"URL":"https:\/\/doi.org\/10.1007\/s11255-019-02172-8","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,25]]},"assertion":[{"value":"9 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures involving human participants were performed in accordance with the ethical standards of the institutional research committee and the 1964 Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}